current word count 268, AJCN limit: 300): 1 Background: Alcohol intake influences plasma lipid levels and such effects may be 2
Conclusions:
In conclusion, this study applied new gene-based statistical approaches to 23
Introduction 29
Plasma lipid profiles, including high-density lipoprotein cholesterol (HDL-c), low-30 density lipoprotein cholesterol (LDL-c), and triglyceride (TG) levels have been well 31 characterized for their roles in the development and prevention of cardiovascular disease (CVD) 32
(1, 2). Genome-wide association studies (GWAS) and advanced DNA sequence technology have 33 uncovered more than two hundred genetic loci influencing lipid levels (3) (4) (5) (6) (7) (8) (9) , and these common 34
(minor allele frequency [MAF] >5%) single nucleotide polymorphisms (SNPs) often reside in 35 non-coding regions of the genome. In addition to the evidence that genetic factors affect plasma 36 lipid profiles, environmental factors influence lipid levels as well. Epidemiologic studies have 37 demonstrated an association between moderate alcohol consumption and improved lipid profile, 38
including higher HDL-C levels, HDL particle concentration, and HDL-C subfractions (10, 11) . 39 However, the association between alcohol use and LDL-C or TG levels is unclear. Some studies 40
reported positive associations while others reported negative associations (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) . 41
Studying gene-by-environment (G×E) interactions is important, as it extends our 42 knowledge of the genetic architecture of complex traits and improves our understanding of the 43 underlying mechanisms of common diseases for novel and known loci (22) (23) (24) . Several large-44 scale genome-wide G×E studies have successfully identified novel common variants accounting 45 for the environmental effects such as alcohol consumption and smoking status on lipid levels and 46 other CVD related traits (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) . These studies have successfully identified common variant loci 47 that were not detected via analysis of main effects alone. However, unlike well-established G×E 48 interaction tests for common variants (35, 36) , methods for detecting rare variant G×E 49 interactions are emerging. Recently developed novel approaches for testing rare variant G×E 50 interaction effects include a joint test that allows for simultaneous testing of the genetic main 51 effect and interaction effect as well as the ability to assess gene-based GxE interactions (37) . 52
Accounting for the effect of alcohol consumption in defining the genetic architecture of 53 lipid levels may not only provide valuable insights into relationship between alcohol 54 consumption and lipids, but also may help refine association signals at previously identified 55 GWAS loci or identify new loci. This study is the first to incorporate G×E interaction in 56 modeling rare and low-frequency variant genetic and alcohol effects on plasma lipid levels. 57
58

Methods 59
Overview of participating studies 60
This study includes 66,428 men and women between 18-80 years of age from 11 61
European-ancestry population studies that are part of the CHARGE Gene-Lifestyle Interactions 62
Working Group (24 FamHS, GENOA, MESA) in samples with TG ≤ 400 mg/dL. LDL-C levels were adjusted for 80 use of statins: if LDL-C levels were directly assayed, LDL-C levels were adjusted for lipid-81 lowering medication use by dividing the original levels by 0.7, otherwise, LDL-C levels were 82 adjusted by first dividing total cholesterol by 0.8, and then using the corrected total cholesterol 83 level in the Friedewald equation. When information on statin-specific use was unavailable, LDL-84 C levels were adjusted for use of unspecified lipid-lowering medication, but only if lipid 85 measurements were performed after 1994. Due to their skewed distributions, HDL-C and TG 86 were natural log transformed prior to analyses. 87
Alcohol consumption was assessed using two dichotomized self-reported alcohol 88 consumption variables: "current drinker" status, defined as any recurrent drinking behavior, and 89 "regular drinker" status, as the subset of current drinkers who consume at least two drinks per 90
week (33) . For this study, definition of "a drink" is approximately 13g of pure ethanol, and this 91 measure was used to standardize the definitions across studies. 92
Genotyping and quality control 93
Genotyping was performed using the Illumina or Affymetrix Human Exome array v1 or 94 v1.1. To improve accurate calling of rare variants, genotyped data from 10 CHARGE 95
Consortium studies were jointly called (39) . Using the curated clustering files from the 96 CHARGE joint calling effort, several cohorts within our study re-called their genotypes. For the 97 remainder of participating studies, genotypes were determined using either BeadStudio or Zcall 98 (40) . Detailed information regarding the genotyping platform for each study is presented in 99 Supplemental Table 1 . All studies performed the following sample-level quality control steps: 100 call rate <95%, autosomal heterozygosity outliers, gender discordance, GWAS discordance (if 101 GWAS data available), ethnic outlier in a principal components analysis. Variants were removed 102 by filtering for Hardy-Weinberg equilibrium test p-value (pHWE) < 5×10 -6 , call rate <95%, and 103 poorly clustering variants. 104
Study-specific association analyses 105
Statistical analyses were performed within each study using the gene-based rareGE R 106 package (37) , and were performed for each lipid/alcohol consumption combination for a total of 107 six combinations. Two types of analyses were considered: 1) a GxE test that considers the 108 genetic main effects as fixed/random effects, and 2) a joint analysis of the genetic main and the 109 GxE interaction effects. Rare and low-frequency (MAF ≤ 5%) functional variants (i.e. 110 frameshift, nonsynonymous, stop/gain, stop/loss, and splicing) were aggregated within genes. 111
Genes with 0 or only 1 rare and low-frequency variant, or genes with a cumulative minor allele 112 count ≤ 10 were not analyzed within each study. Models were adjusted for age, sex, principal 113 components (PCs) and additionally study-specific covariates as presented in Supplemental Table  114 1. 115
Meta-analyses 116
A weighted Z-test using square root of sample sizes as weights was used to meta-analyze 117 study-specific p-values for genes present in at least 2 discovery studies (41) . Genes of interest 118 from the discovery phase with a p-value < 5×10 -5 were pursued for replication. For these select 119 genes, we used the same approaches as in discovery studies to perform meta-analysis of the 120 replication studies. Significance was determined using a Bonferroni correction for the number of 121 gene-lipid pairs taken forward to replication (p-value < 0.05/30 = 0.0017 for analysis of the joint 122 test of genetic main and interaction effects, p-value <0.05/4 = 0.013 for analysis of the 123 interaction effects). 124
Additional analyses: conditional and single variant tests 125
For each replicated gene-lipid pair, additional analyses were conducted following the 126 flowchart shown in Figure 1 . For genes +/-500kb bp from previously reported lipid loci (42) , 127 conditional analyses were performed to identify aggregated rare and low-frequency variants 128 associated with lipids independent of the previously reported common index single nucleotide 129 polymorphism (SNP) (42) . Results from study-specific conditional analyses were meta-analyzed 130 using a weighted Z-test, separately in discovery and replication. For novel genes and known 131 genes that remained significant after conditional analyses, we performed single variant tests for 132 each variant (MAF ≤ 5% and minor allele count ≥ 5) that was included in the aggregate test in 133 order to identify the driving variants within these genes. We obtained robust estimates of 134 covariance matrices and robust standard errors from each study and implemented METAL to 135 jointly meta-analyze the genetic main and interaction effects (36, 43) , and to meta-analyze the 136 interaction coefficients alone using inverse-variance weighted meta-analysis for each single 137 variant within selected genes. 138
Results 140
Descriptive statistics for the discovery and replication studies are summarized in Table 1  141 and Supplemental Table 1 . On average, two thirds of the study participants were current drinkers 142 and 39.5 percent were regular drinkers. The proportion of current and regular drinkers was 143 greater for the discovery studies as compared to the replication studies. 144
Overall, meta-analysis showed highly consistent results across current drinker and regular 145 drinker (Supplemental Table 2 ). Distributions of QQ plots for meta-analyzing discovery studies 146 are shown in Supplemental Figure 1 . In the discovery phase, we observed 31 gene-lipid 147 associations (p-value < 5×10 -5 ) in the joint analysis and 5 gene-lipid associations (p-value < 148 5×10 -5 ) in the interaction test, with 3 genes overlapping between the two approaches 149 (Supplemental Table 2 ). These gene-lipid pairs were taken forward for replication, one of which 150 (IDNK) was only available in one replication study (the CHS). Therefore, we evaluated 30 gene-151 lipid associations for replication using the joint test and 4 using gene-alcohol interaction 152 (Supplemental Table 2 ). Thirteen known lipid loci (21 gene-lipid associations) were replicated 153 and one novel interaction were replicated for the SMC5-by-current drinker interaction on TG 154 levels ( Table 2) . Among the replicated genes, 4 were shared between TG and HDL-C but none 155 were shared between LDL-C and TG or HDL-C, as shown in a Venn diagram (Figure 2) . 156
For the 13 known lipid loci that were replicated through the joint test, we performed 157 conditional analyses in order to examine whether the gene-based rare variant effects are 158 independent of the common index SNP identified by previous GWAS. In total, 8 loci (PCSK9, 159 LPA, LPL, LIPG, ANGPTL4, APOB, APOC3 and CD300LG) (10 gene-lipid associations) 160 remained significant after conditioning on a common index SNP. However, genes at known lipid 161 loci yet these genes themselves were not previously reported to be associated with lipids, such as 162 BCAM and CBLC on LDL-C, were strongly attenuated after adjusting for rs7412, the index SNPs 163 of APOE identified by previous GWAS (Supplemental Table 3 ). 164
Single variant analyses were performed for the 5 gene-lipid associations that were not 165 evaluated in the conditional analyses because they did not have previously reported common 166
SNPs and for the 10 gene-lipid pairs that remained significant following conditional analyses 167 (Figure 1, Supplemental Table 3 ). Single variant tests at these genes confirmed previous known 168 low-frequency lipid variants. For example, rs11591147 in PCSK9 was associated with LDL-C, 169 and rs77960347 in LIPG and rs116843064 in ANGPTL4 were associated with HDL-C. 170
Additionally, we provide evidence that two of the driving variants underlying the joint test 171 results are novel rare variants associated with LDL-c (Supplemental Table 4 ). One of them is 172 rs41267813, a variant in the LPA gene (p = 6.55×10 -29 discovery, p = 1.83×10 -03 replication) and 173 the other is rs41288783 of APOB gene (p = 5.40×10 -08 discovery, p = 7.92×10 -07 replication). For 174 the novel interaction between SMC5 and current drinker on TG levels, we identified the driving 175 variant as rs142488686, a missense mutation (MAC = 5-7 discovery (ARIC and CARDIA), 176 MAC = 7-17 replication (WGHS, CHS and MESA)), with positive interaction effect (p = 0.016 177 discovery, p = 0.008 replication), while the genetic main effect was modest (p < 0.1 discovery 178 and replication, respectively). 179 180 Discussion 181 This is the first large-scale study to evaluate the role of rare and low frequency variants in 182 lipids by incorporating gene-alcohol consumption interactions. We tested for gene-alcohol 183 interaction effect on lipid levels as well as the joint effects of genetic main and gene-alcohol 184 interactions. We replicated 13 gene-lipid associations at known lipid loci, among which 2 185 leading rare variants in APOB and LPA genes associated with LDL-c were novel. Only one novel 186 gene-alcohol interaction was identified as significant and successfully replicated (the interaction 187 between rare and low-frequency variants in SMC5 and current drinker on TG levels). 188
Using a single variant test, we confirmed previously identified rare and low-frequency 189 lipid variants. For example, rs11591147 of PCSK9 has been associated with LDL-c levels (44) , 190 rs77960347 of LIPG and rs116843064 of ANGPTL4 have been associated with HDL-c levels 191 (45, 46) . A loss of function mutation in the APOC3 gene, rs147210663, has been associated with 192 a more than 40% lower average triglyceride level in individuals carrying one A allele (47, 48) . In 193 the present study, we observed a novel relationship between increased HDL-c levels in 194 individuals carrying rs147210663 (A) allele as rs147210663 was previously reported as a 195 founder mutation in a Pennsylvania Amish population (49). 196 Between the two novel rare driving variants we identified and replicated, rs41267813 197 (LPA) is located close to a stop/gain variant rs41267811 (LPA) that was also significantly 198 associated with LDL-c levels in the discovery phase. However, we were unable to replicate the 199 association with rs41267811 as it was only available in one replication study (WGHS) and 200 therefore did not meet our criteria to be included in replication. LPA encoded protein constitutes 201 a substantial portion of lipoprotein(a) and associated with inherited conditions including type III 202 hyperlipoproteinemia and familial hyperlipidemia (50) . A stop/gain mutation in this gene would 203 be associated with lower LDL-C levels in carriers, which is true among non-drinkers. However, 204 such effect may be modified by alcohol consumption as we observed the carriers of this variant 205 with a higher LDL-C levels compared to non-carriers in a population who had at least two drinks 206 per week in the ARIC study. Previous studies have reported a relationship between moderate 207 alcohol consumption and lower Lp(a) lipoprotein concentrations (51, 52) , but there was no 208 existing evidence linking genetic variants of LPA to alcohol consumption. Although the 209 underlying biology of the observed modification effect of alcohol consumption on rs41267813 210 and LDL-c associations remained unclear, we hypothesize that alcohol modifies the LPA 211 expression for carriers of rs41267813, therefore modifies LDL-c levels. 212
In addition to the variant described above, the other driving rare variant had not been 213 previously associated with a lipid trait, rs41288783 (p.Pro994Leu), a deleterious variant in 214 APOB gene. A previous study reported its existence in a patient who was clinically diagnosed as 215 familial hypercholesterolaemia (FH) without a detectable mutation (53) . FH is characterized by 216 very high levels of LDL-c, and we observed an association with higher LDL-c levels though 217 jointly testing the effects of rs41288783 and its interaction with alcohol consumption. 218
Nevertheless, the exact biological function of rs41288783 remains unknown. We note that a 219
Mendelian randomization study has suggested a causal role of alcohol consumption in reducing 220 plasma apo B and LDL-c levels in a general population (54) . Considering this, alcohol 221 consumption may have contributed to the observed significant joint effect of APOB and alcohol 222 consumption on LDL-c levels. 223
For the significant gene-alcohol interaction effect we observed on TG levels, the driving 224 variant was identified as rs142488686, a missense mutation in SMC5 (Structural Maintenance Of 225 Chromosomes 5). SMC5 encodes a core component involved in repair of DNA double-strand 226 breaks and required for telomere maintenance (55) (56) (57) . Variants in SMC5 have not been 227 previously reported to be associated with lipid levels nor alcohol consumption, and it is unknown 228 whether the interaction between SMC5 locus and current drinking behavior on TG levels has a 229 biological aspect. 230 A limitation of this study is the imbalance in percentage of alcohol consumers between 231 discovery (on average 48.7% regular drinker, 78.5% current drinker) and replication studies (on 232 average 29.8% regular drinker, 57.2% current drinker) which may have impacted our ability to 233 identify and replicate additional loci beyond what is reported here. Additionally, as self-reported 234 alcohol consumption was used and may very likely be underreported, this study may suffer from 235 loss of statistical power due to potential misclassification (58) . Similarly, dichotomizing alcohol 236 consumption into regular drinkers and current drinkers may also reduce power as compared to 237 treating it as a continuous variable (59) . It is possible that a more comprehensive characterization 238 of alcohol consumption could reveal associations that were missed in the present study. In 239 addition, although the sample size of 66,428 may seem sufficient for a traditional GWAS, to 240 identify additional novel loci while focusing on rare variants and gene-environment interactions 241 may require larger sample size or bigger effect size (23, 60) . 242
In conclusion, this study applied emerging statistical approaches to investigate the role of 243 rare and low-frequency variants in gene-alcohol consumption interaction effects on lipid levels, 244 and identified 2 novel rare variants at know lipid loci for LDL-c levels and 1 novel gene-alcohol 245 interaction for TG levels. Our results show promise for other larger scale studies analyzing rare 246 variant GxE interactions to refine association signals at previously identified loci to reveal novel 247 biology. For single variant test to identify driving rare variants, we applied Bonferroni correction for number of SNPs tested in discovery phase and number of SNPs taken forward to replication separately for joint test and interaction test for each lipid trait.
Figure 2. Genes as revealed by GxE interaction test or jointly testing the gene and GxE
interaction effects in association with plasma lipid levels. Bolded genes were genes remained significant after conditioning on common index SNPs. Genes in red were not previously reported to be associated with one or more lipid traits
